1. Home
  2. PCRX vs USNA Comparison

PCRX vs USNA Comparison

Compare PCRX & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • USNA
  • Stock Information
  • Founded
  • PCRX 2006
  • USNA 1992
  • Country
  • PCRX United States
  • USNA United States
  • Employees
  • PCRX N/A
  • USNA N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • PCRX Health Care
  • USNA Health Care
  • Exchange
  • PCRX Nasdaq
  • USNA Nasdaq
  • Market Cap
  • PCRX 604.7M
  • USNA 648.2M
  • IPO Year
  • PCRX 2011
  • USNA 1996
  • Fundamental
  • Price
  • PCRX $23.33
  • USNA $34.45
  • Analyst Decision
  • PCRX Buy
  • USNA Hold
  • Analyst Count
  • PCRX 10
  • USNA 1
  • Target Price
  • PCRX $27.60
  • USNA $38.00
  • AVG Volume (30 Days)
  • PCRX 644.2K
  • USNA 132.9K
  • Earning Date
  • PCRX 02-27-2025
  • USNA 02-25-2025
  • Dividend Yield
  • PCRX N/A
  • USNA N/A
  • EPS Growth
  • PCRX N/A
  • USNA N/A
  • EPS
  • PCRX N/A
  • USNA 2.83
  • Revenue
  • PCRX $694,957,000.00
  • USNA $861,973,000.00
  • Revenue This Year
  • PCRX $4.83
  • USNA N/A
  • Revenue Next Year
  • PCRX $2.16
  • USNA $11.73
  • P/E Ratio
  • PCRX N/A
  • USNA $12.16
  • Revenue Growth
  • PCRX 4.40
  • USNA N/A
  • 52 Week Low
  • PCRX $11.16
  • USNA $31.44
  • 52 Week High
  • PCRX $34.01
  • USNA $52.75
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 72.60
  • USNA 44.44
  • Support Level
  • PCRX $18.18
  • USNA $33.34
  • Resistance Level
  • PCRX $22.36
  • USNA $34.89
  • Average True Range (ATR)
  • PCRX 1.22
  • USNA 0.95
  • MACD
  • PCRX 0.32
  • USNA 0.07
  • Stochastic Oscillator
  • PCRX 96.63
  • USNA 34.54

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Share on Social Networks: